Reaction

Kaposi'S Sarcoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 503 reports · 23 co-occurring drugs

As of the last recalculation, Kaposi'S Sarcoma appears in 503 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is LAMIVUDINE (PRR 154.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Lamivudine94154.6155.1
Lamivudine Oral75144.0144.4
Lopinavir And Ritonavir42139.8140.2
Nevirapine25120.6120.9
Zidovudine35116.3116.6
Abacavir Sulfate2297.797.9
Efavirenz2597.697.8
Atazanavir2988.688.7
Ritonavir 100 Mg2985.285.3
Ritonavir5282.082.2
Cyclosporine10951.551.5
Pyrazinamide1044.945.0
Basiliximab1139.539.6
Rifampicin937.537.5
Daspone834.534.5
Dapsone Gel, 5%834.534.5
Dapsone831.531.5
Isoniazid1231.431.4
Sirolimus1031.331.3
Emtricitabine And Tenofovir Disoproxil Fumarate3028.928.9
Tenofovir Disoproxil Fumarate1924.724.7
Bleomycin Sulfate624.324.3
Tenofovir Disoproxil Fumarate Tablets524.224.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.